Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 3/20 | 0.75 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.75 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.65 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.65 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | SCN1A | P35498 | 1/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29825075 | 1.00 | ADRA1A (0.75) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Hydrochloric Acid SCHEMBL10365566 | 0.98 | ADRA1A (0.73) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| SCHEMBL29172261 | 0.86 | ADRA1A (0.71) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| SCHEMBL15756621 | 0.86 | ADRA1A (0.71) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Desglymidodrine SCHEMBL29822558 | 0.86 | ADRA1A (1.00) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Desglymidodrine SCHEMBL6031919 | 0.86 | ADRA1A (1.00) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Desglymidodrine SCHEMBL29583490 | 0.86 | ADRA1A (1.00) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Desglymidodrine SCHEMBL6032882 | 0.86 | ADRA1A (1.00) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| SCHEMBL9173075 | 0.86 | ADRA2A (0.56) | ADRA1AADRA2AADRB2ADRB1ADRB3 | |
| Desglymidodrine SCHEMBL476432 | 0.86 | ADRA1A (1.00) | ADRA1AADRA2AADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9944581-B2 | Processes for converting biomass-derived feedstocks to chemicals and liquid fuels | VIRENT, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9765261-B2 | Solvolysis of biomass to produce aqueous and organic products | VIRENT, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170247307-A1 | PROCESSES FOR CONVERTING BIOMASS-DERIVED FEEDSTOCKS TO CHEMICALS AND LIQUID FUELS | VIRENT INC (US) | 2017-08-31 | — | — | US | disclosed |
| US-9656937-B2 | Processes for converting biomass-derived feedstocks to chemicals and liquid fuels | VIRENT, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170137719-A1 | SOLVOLYSIS OF BIOMASS TO PRODUCE AQUEOUS AND ORGANIC PRODUCTS | VIRENT, INC. (US) | 2017-05-18 | — | — | US | disclosed |
| US-9587178-B2 | Solvolysis of biomass to produce aqueous and organic products | VIRENT, INC. (US) | 2017-03-07 | — | — | US | disclosed |
| US-20160304427-A1 | PROCESSES FOR CONVERTING BIOMASS-DERIVED FEEDSTOCKS TO CHEMICALS AND LIQUID FUELS | VIRENT, INC. | 2016-10-20 | — | — | US | disclosed |
| US-9388528-B2 | Solvolysis of biomass to produce aqueous and organic products | VIRENT, INC. (US) | 2016-07-12 | — | — | US | disclosed |
| US-9382185-B2 | Processes for converting biomass-derived feedstocks to chemicals and liquid fuels | VIRENT, INC. (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160024711-A1 | SOLVOLYSIS OF BIOMASS TO PRODUCE AQUEOUS AND ORGANIC PRODUCTS | VIRENT, INC. | 2016-01-28 | — | — | US | disclosed |
| US-9157030-B2 | Solvolysis of biomass and stabilization of biomass hydrolysate | VIRENT, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| US-9157031-B2 | Solvolysis of biomass to produce aqueous and organic products | VIRENT, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| US-20140350097-A1 | TREATMENT OF HYPOTENSION ASSOCIATED WITH HEMODIALYSIS | Medinox,Inc. (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140273118-A1 | Processes for Converting Biomass-Derived Feedstocks to Chemicals and Liquid Fuels | VIRENT, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130019859-A1 | SOLVOLYSIS OF BIOMASS AND STABILIZATION OF BIOMASS HYDROLYSATE | VIRENT, INC. (US) | 2013-01-24 | — | — | US | disclosed |
| US-20130023702-A1 | Serial Deconstruction of Biomass | VIRENT, INC. (US) | 2013-01-24 | — | — | US | disclosed |
| US-20120323053-A1 | Methods for biomass Deconstruction and Purification | VIRENT, INC. (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120318258-A1 | SOLVOLYSIS OF BIOMASS TO PRODUCE AQUEOUS AND ORGANIC PRODUCTS | VIRENT, INC. (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120101091-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-20110306597-A1 | Nicotinamide Derivatives | CRAWFORTH JAMES MICHAEL (GB) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350097-A1 | TREATMENT OF HYPOTENSION ASSOCIATED WITH HEMODIALYSIS | NOS2, QDPR, NOS1 | ADRA1A 252/4885ADRA2A 321/4885ADRB2 158/4885 |
| US-20170247307-A1 | PROCESSES FOR CONVERTING BIOMASS-DERIVED FEEDSTOCKS TO CHEMICALS AND LIQUID FUELS | HPD, GRHPR, CBR3 | ADRA1A 4367/4885ADRA2A 4147/4885ADRB2 3106/4885 |
| US-20140273118-A1 | Processes for Converting Biomass-Derived Feedstocks to Chemicals and Liquid Fuels | HPD, GRHPR, CBR3 | ADRA1A 4367/4885ADRA2A 4147/4885ADRB2 3106/4885 |
| US-20110306597-A1 | Nicotinamide Derivatives | NNT, NAMPT, NQO1 | ADRA1A 745/4885ADRA2A 1110/4885ADRB2 673/4885 |
| US-20120101091-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2H, POLR2E | ADRA1A 2783/4885ADRA2A 3168/4885ADRB2 3693/4885 |
| US-20160304427-A1 | PROCESSES FOR CONVERTING BIOMASS-DERIVED FEEDSTOCKS TO CHEMICALS AND LIQUID FUELS | HPD, GRHPR, CBR3 | ADRA1A 4367/4885ADRA2A 4147/4885ADRB2 3106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.